| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |